跳至主要内容
临床试验/NCT00538720
NCT00538720已完成1 期

Pilot Study to Detect and Assess the Effect of Vitamin D Replacement on Gland Size by 4DCT in Patients With Primary Hyperparathyroidism (PHPT)

M.D. Anderson Cancer Center1 个研究点 分布在 1 个国家目标入组 22 人开始时间: 2007年10月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
1 期
状态
已完成
入组人数
22
试验地点
1
主要终点
Size of parathyroid glands

研究概览

简要总结

The goal of this clinical research study is to learn how the standard practice of giving Vitamin D supplements to patients with a Vitamin D deficiency may affect the size of the parathyroid glands in patients with PHPT and a Vitamin D deficiency.

详细描述

The Study Vitamin:

In patients with PHPT and a Vitamin D deficiency, Vitamin D supplements are routinely given to bring Vitamin D blood levels up to a normal level before surgery on any abnormal parathyroid glands. When patients have Vitamin D deficiency, they do not absorb calcium very well, so the parathyroid glands have to work harder. This may cause the parathyroid glands to become larger.

Baseline:

If you are found to be eligible to take part in this study, as part of your routine standard of care, you will have a 4-dimensional computed tomography (4DCT) scan of the neck. This 4DCT will be used to find the size and location of your parathyroid glands to help the surgeon in planning the surgery.

Vitamin D Administration:

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
21 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Be diagnosed with PHPT (inappropriate PTH level in the setting of a high or high-normal corrected serum calcium level equal to or greater than 10.0 mg/dL)
  • Be considered an appropriate surgical candidate
  • Be older than 21 years of age
  • Have a vitamin D (25-OHD) level less than or equal to 20ng/ml
  • Female participants of childbearing potential must have a negative pregnancy test (urinary or serum beta-HCG) within two weeks before signing consent

排除标准

  • Have any other functional tumors if they have familial multiple endocrine neoplasia syndrome 1 or 2 (MEN 1 or MEN 2)
  • Have a corrected calcium level greater than 13mg/dL
  • Have a recent history of kidney stones
  • Have a recent history of pancreatitis
  • Have a recent history of cardiac arrhythmia (eg atrial fibrillation)
  • Unable to keep still for 2 minutes without coughing
  • Having a body habitus that prevents adequate images to be obtained through the region of the parathyroids (ie typically weighing in excess of 250Lbs)
  • Have a serum creatinine greater than 2.0 mg/dl
  • Have hypersensitivity to ergocalciferol or any component of the formulation

研究组 & 干预措施

Vitamin D

Experimental

Vitamin D starting dose 50,000 IU by mouth 3 times weekly for three weeks (+/- one week), then 50,000 IU twice weekly for 6 weeks (+/- one week).

干预措施: Vitamin D (Drug)

Vitamin D

Experimental

Vitamin D starting dose 50,000 IU by mouth 3 times weekly for three weeks (+/- one week), then 50,000 IU twice weekly for 6 weeks (+/- one week).

干预措施: Four-dimensional computed tomography (4DCT) (Device)

结局指标

主要结局

Size of parathyroid glands

时间窗: Baseline to 3-months post treatment

Size of individual gland recorded while only the gland with maximum size at baseline included for analysis of primary endpoint. With sample size of 22, a two-sided 95% confidence interval for mean changes in size of parathyroid glands will extend 2.09 from observed mean, assuming that standard deviation is known to be 5 and confidence interval is based on the z statistic. Parameters for parathyroid glands compared pre- and post-replacement on an individual, gland-by-gland basis.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Effects of Vitamin D Replacement in Patients With... | 临床试验